ID   GPC1_RAT                Reviewed;         558 AA.
AC   P35053;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   27-MAR-2024, entry version 136.
DE   RecName: Full=Glypican-1;
DE   AltName: Full=HSPG M12;
DE   Contains:
DE     RecName: Full=Secreted glypican-1;
DE   Flags: Precursor;
GN   Name=Gpc1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 24-55 AND 424-445.
RC   TISSUE=Brain;
RX   PubMed=1417860; DOI=10.1016/0006-291x(92)92398-h;
RA   Karthikeyan L., Maurel P., Rauch U., Margolis R.K., Margolis R.U.;
RT   "Cloning of a major heparan sulfate proteoglycan from brain and
RT   identification as the rat form of glypican.";
RL   Biochem. Biophys. Res. Commun. 188:395-401(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND PROTEIN SEQUENCE OF
RP   83-112; 196-207 AND 422-443.
RC   STRAIN=New England Deaconess Hospital;
RX   PubMed=8207484; DOI=10.1523/jneurosci.14-06-03713.1994;
RA   Litwack E.D., Stipp C.S., Kumbasar A., Lander A.D.;
RT   "Neuronal expression of glypican, a cell-surface
RT   glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the
RT   adult rat nervous system.";
RL   J. Neurosci. 14:3713-3724(1994).
RN   [3]
RP   COPPER-BINDING, GLYCOSYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=14707133; DOI=10.1074/jbc.m313678200;
RA   Mani K., Cheng F., Havsmark B., David S., Fransson L.A.;
RT   "Involvement of glycosylphosphatidylinositol-linked ceruloplasmin in the
RT   copper/zinc-nitric oxide-dependent degradation of glypican-1 heparan
RT   sulfate in rat C6 glioma cells.";
RL   J. Biol. Chem. 279:12918-12923(2004).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15383532; DOI=10.1074/jbc.m408837200;
RA   Rothblum K., Stahl R.C., Carey D.J.;
RT   "Constitutive release of alpha4 type V collagen N-terminal domain by
RT   Schwann cells and binding to cell surface and extracellular matrix heparan
RT   sulfate proteoglycans.";
RL   J. Biol. Chem. 279:51282-51288(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16407548; DOI=10.1523/jneurosci.2544-05.2006;
RA   Chernousov M.A., Rothblum K., Stahl R.C., Evans A., Prentiss L.,
RA   Carey D.J.;
RT   "Glypican-1 and alpha4(V) collagen are required for Schwann cell
RT   myelination.";
RL   J. Neurosci. 26:508-517(2006).
CC   -!- FUNCTION: Cell surface proteoglycan that bears heparan sulfate. May act
CC       as a catalyst in increasing the rate of conversion of prion protein
CC       PRPN(C) to PRNP(Sc) via associating (via the heparan sulfate side
CC       chains) with both forms of PRPN, targeting them to lipid rafts and
CC       facilitating their interaction. Required for proper skeletal muscle
CC       differentiation by sequestering FGF2 in lipid rafts preventing its
CC       binding to receptors (FGFRs) and inhibiting the FGF-mediated signaling.
CC       Binds Cu(2+) or Zn(2+) ions (By similarity). Binds, via the heparan
CC       sulfate side chains, alpha-4 (V) collagen and participates in Schwann
CC       cell myelination. {ECO:0000250, ECO:0000269|PubMed:15383532,
CC       ECO:0000269|PubMed:16407548}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor;
CC       Extracellular side. Endosome {ECO:0000250}. Note=S-nitrosylated form
CC       recycled in endosomes. Localizes to CAV1-containing vesicles close to
CC       the cell surface. Cleavage of heparan sulfate side chains takes place
CC       mainly in late endosomes. Associates with both forms of PRNP in lipid
CC       rafts. Colocalizes with APP in perinuclear compartments and with CP in
CC       intracellular compartments (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Secreted glypican-1]: Secreted, extracellular
CC       space {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Nervous system. {ECO:0000269|PubMed:8207484}.
CC   -!- PTM: S-nitrosylated in a Cu(2+)-dependent manner. Nitric acid (NO) is
CC       released from the nitrosylated cysteines by ascorbate or by some other
CC       reducing agent, in a Cu(2+) or Zn(2+) dependent manner. This free
CC       nitric oxide is then capable of cleaving the heparan sulfate side
CC       chains.
CC   -!- PTM: N- and O-glycosylated. N-glycosylation is mainly of the complex
CC       type containing sialic acid. O-glycosylated with heparan sulfate. The
CC       heparan sulfate chains can be cleaved either by the action of
CC       heparanase or, degraded by a deaminative process that uses nitric oxide
CC       (NO) released from the S-nitrosylated cysteines. This process is
CC       triggered by ascorbate, or by some other reducing agent, in a
CC       Cu(2+)- or Zn(2+) dependent manner. Cu(2+) ions are provided by
CC       ceruloproteins such as APP, PRNP or CP which associate with GCP1 in
CC       intracellular compartments or lipid rafts.
CC       {ECO:0000269|PubMed:14707133}.
CC   -!- PTM: This cell-associated glypican is further processed to give rise to
CC       a medium-released species.
CC   -!- SIMILARITY: Belongs to the glypican family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L02896; AAA86439.1; -; mRNA.
DR   EMBL; L34067; AAA41251.1; -; mRNA.
DR   PIR; I56545; I56545.
DR   RefSeq; NP_110455.1; NM_030828.1.
DR   AlphaFoldDB; P35053; -.
DR   SMR; P35053; -.
DR   BioGRID; 248661; 3.
DR   IntAct; P35053; 1.
DR   STRING; 10116.ENSRNOP00000066597; -.
DR   GlyCosmos; P35053; 5 sites, 3 glycans.
DR   GlyGen; P35053; 5 sites, 3 N-linked glycans (1 site).
DR   iPTMnet; P35053; -.
DR   PhosphoSitePlus; P35053; -.
DR   jPOST; P35053; -.
DR   PaxDb; 10116-ENSRNOP00000066597; -.
DR   GeneID; 58920; -.
DR   KEGG; rno:58920; -.
DR   AGR; RGD:61853; -.
DR   CTD; 2817; -.
DR   RGD; 61853; Gpc1.
DR   eggNOG; KOG3821; Eukaryota.
DR   InParanoid; P35053; -.
DR   OrthoDB; 2939408at2759; -.
DR   PhylomeDB; P35053; -.
DR   Reactome; R-RNO-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-RNO-2022928; HS-GAG biosynthesis.
DR   Reactome; R-RNO-2024096; HS-GAG degradation.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-975634; Retinoid metabolism and transport.
DR   PRO; PR:P35053; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0031012; C:extracellular matrix; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098552; C:side of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0070052; F:collagen V binding; IPI:RGD.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:0017134; F:fibroblast growth factor binding; ISS:UniProtKB.
DR   GO; GO:0043236; F:laminin binding; ISS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0030200; P:heparan sulfate proteoglycan catabolic process; ISS:UniProtKB.
DR   GO; GO:0032288; P:myelin assembly; IDA:UniProtKB.
DR   GO; GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:2001016; P:positive regulation of skeletal muscle cell differentiation; ISS:UniProtKB.
DR   GO; GO:1905475; P:regulation of protein localization to membrane; IBA:GO_Central.
DR   GO; GO:0014037; P:Schwann cell differentiation; IDA:UniProtKB.
DR   InterPro; IPR001863; Glypican.
DR   InterPro; IPR019803; Glypican_CS.
DR   PANTHER; PTHR10822; GLYPICAN; 1.
DR   PANTHER; PTHR10822:SF8; GLYPICAN-1; 1.
DR   Pfam; PF01153; Glypican; 1.
DR   PROSITE; PS01207; GLYPICAN; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Copper; Direct protein sequencing; Disulfide bond; Endosome;
KW   Glycoprotein; GPI-anchor; Heparan sulfate; Lipoprotein; Membrane;
KW   Proteoglycan; Reference proteome; Secreted; Signal; Zinc.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:1417860"
FT   CHAIN           24..530
FT                   /note="Glypican-1"
FT                   /id="PRO_0000012299"
FT   CHAIN           24..?
FT                   /note="Secreted glypican-1"
FT                   /id="PRO_0000333839"
FT   PROPEP          531..558
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000012300"
FT   REGION          478..531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           530
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        79
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:14707133"
FT   CARBOHYD        116
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000305|PubMed:14707133"
FT   CARBOHYD        486
FT                   /note="O-linked (Xyl...) (heparan sulfate) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        488
FT                   /note="O-linked (Xyl...) (heparan sulfate) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        490
FT                   /note="O-linked (Xyl...) (heparan sulfate) serine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        32..68
FT                   /evidence="ECO:0000250"
FT   DISULFID        62..256
FT                   /evidence="ECO:0000250"
FT   DISULFID        69..259
FT                   /evidence="ECO:0000250"
FT   DISULFID        191..343
FT                   /evidence="ECO:0000250"
FT   DISULFID        246..279
FT                   /evidence="ECO:0000250"
FT   DISULFID        268..415
FT                   /evidence="ECO:0000250"
FT   DISULFID        272..401
FT                   /evidence="ECO:0000250"
FT   CONFLICT        21
FT                   /note="T -> A (in Ref. 2; AAA41251)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        312
FT                   /note="Y -> N (in Ref. 2; AAA41251)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        362
FT                   /note="A -> G (in Ref. 2; AAA41251)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        437
FT                   /note="I -> G (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        443
FT                   /note="E -> D (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        515
FT                   /note="I -> T (in Ref. 2; AAA41251)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   558 AA;  61734 MW;  E2878A854B9A1D7F CRC64;
     MELRARGWWL LCAAAALVAC TRGDPASKSR SCSEVRQIYG AKGFSLSDVP QAEISGEHLR
     ICPQGYTCCT SEMEENLANH SRMELETALH DSSRALQATL ATQLHGIDDH FQRLLNDSER
     TLQDAFPGAF GDLYTQNTRA FRDLYAELRL YYRGANLHLE ETLAEFWARL LERLFKQLHP
     QLLLPDDYLD CLGKQAEALR PFGDAPRELR LRATRAFVAA RSFVQGLGVA SDVVRKVAQV
     PLAPECSRAV MKLVYCAHCR GVPGARPCPD YCRNVLKGCL ANQADLDAEW RNLLDSMVLI
     TDKFWGPSGA EYVIGSVHMW LAEAINALQD NKDTLTAKVI QGCGNPKVNP HGSGPEEKRR
     RAKLALQEKS STGTLEKLVS EAKAQLRDIQ DYWISLPGTL CSEKMAMSPA SDDRCWNGIS
     KGRYLPEVMG DGLANQINNP EVEVDITKPD MTIRQQIMQL KIMTNRLRGA YGGNDVDFQD
     ASDDGSGSGS GGGCPDDACG RRVSKKSSSS RTPLIHALPG LSEQEGQKTS AATRPEPHYF
     FLLFLFTLVL AAARPRWR
//
